Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BrainCool AB (publ) draws down a third tranche of convertible notes of SEK 5 million

BrainCool AB (publ) ("BrainCool" and the "Company") has signed an amendment agreement relating to the investment agreement entered into on 22 November 2017 with European Select Growth Opportunities Fund (the "Investor") and draws down a third tranche of SEK 5 million under the investment agreement.BrainCool entered into on 22 November 2017 an investment agreement with the Investor (the "Agreement"). On 4 November 2018, BrainCool and the Investor signed an amendment agreement relating to the Agreement (the “Amendment Agreement") providing inter alia: · In order to facilitate the

“Green Deal” at Expoprotection Paris 2018: Collaboration between industrial partnership wear2wear and France’s recycling project FRIVEP

French companies and government agencies will in future feed tons of used protective workwear back into the textile loop of European upcycling consortium wear2wear for value-retaining reutilisation of polyester fabric.Munich / Paris, 5 November 2018 – At the Expoprotection Paris (6 - 8 November), wear2wear will present its next decisive move towards establishing closed-loop textile recycling across national European boundaries and economies: through intermediary Sympatex – a member of both partnerships – the European textile partnership (which introduced its first upcycling project at the

INVITATION TO TELECONFERENCE/AUDIO TRANSMISSION

Concordia Maritime welcomes you to participate in a teleconference/ audio transmission November 8 2018, at 03.00 pm CET. The Interim Report for Q3 2018 (published November 8 2018) will be presented and questions answered.Presiding: Kim Ullman, CEO Ola Helgesson, CFO The teleconference will be available at: UK: +442030089802    SE: +46856642696 US: +18558315946 To access the audio transmission, please click on the link below: https://tv.streamfabriken.com/concordia-maritime-q3-2018 Questions can be posed verbally via the teleconference, or in writing via the

Invitation to presentation of Humana’s third quarter report 2018

Humana’s interim report for the third quarter 2018 will be published at 08:00 CET on November 16, 2018. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Rasmus Nerman and CFO Ulf Bonnevier will present the results for the third quarter 2018. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Humana’s financial website, http://corporate.humana.se. The presentation and webcast is also available on www.

ÅF and Ericsson join forces to make manufacturing smart & wireless

ÅF and Ericsson form a partnership in the Scandinavian market to introduce mobile connectivity for industrial applications. The collaboration aims to strengthen the offer towards various industry segments, accelerate digital transformation and solve pain points in production.A new connectivity foundation is necessary to make manufacturing truly smart. With the new standards in mobile connectivity almost every asset can be connected and managed to solve operational challenges. In many cases making wires redundant, production lines can be reconfigured faster for flexible production, issue a

Itiviti wins Waters Buy-Side Technology Award for NYFIX trading network for third consecutive year

London, UK, November 5, 2018 – Itiviti, the leading global provider of multi-asset trading technology and financial infrastructure, is pleased to announce that its NYFIX global connectivity platform has won the “Best Low-Latency Trading Network” category in Waters Buy-Side Technology Awards 2018 – the third consecutive year that NYFIX has won in this category.Hosted by Waters magazine, WatersTechnology and Buy-Side Technology, the awards recognize the leading technologies and vendors serving the global asset management industry. This year, an independent expert panel of nine judges

Precise Biometrics plans to re-organize operations to improve customer service and enable growth in new areas of use

Precise Biometrics plans to re-structure the organization to enable improved customer service and increased focus on solutions that unite various biometric modalities. As part of this planned re-organization, the company will establish a new office in Shanghai during the first half of 2019 and intends to centralize operations in Sweden to the headquarter in Lund, closing the office in Karlstad.In line with Precise Biometrics’ ambition to develop world leading biometrics solutions, the company is planning for a re-organization of some of its operations. A centralization of the Swedish

Full-scale CCS Plant Reduces CO2 Emissions by One Third

A full-scale CCS plant at Preem's refinery in Lysekil would reduce CO2 emissions by one third. Now the company is aiming to build a full-scale facility by 2025. Preem, together with Chalmers and Norwegian research institute SINTEF, has conducted a preliminary study on how Preem's refinery in Lysekil could use CCS, Carbon Capture and Storage, ie to capture and store carbon dioxide. The CCS technology itself is about separating carbon dioxide from the flue gases before being released into the atmosphere. "With the feasibility study we have been able to define the obstacles and

The merger between Tele2 and Com Hem is completed

Stockholm – The Swedish Companies Registration Office (“SCRO”) has today registered the merger between Tele2 AB (publ) (”Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) and Com Hem Holding AB (publ) (“Com Hem Holding”). The merger between Tele2 and Com Hem Holding is thereby completed and Com Hem Holding has been dissolved.SCRO’s registration of the merger completes the merger process from a legal perspective and all of Com Hem Holding’s assets and liabilities have been transferred to Tele2. The merged entity will maintain the company name Tele2 AB (publ) and will continue to have its

Exel Composites Plc: Managers' Transactions – Kytömäki, Riku

EXEL COMPOSITES PLC        MANAGERS’ TRANSACTIONS     5 NOVEMBER 2018 at 9:45 EETPerson subject to the notification requirementName: Kytömäki, RikuPosition: Chief Executive OfficerIssuer: Exel Composites OyjLEI: 743700205JAMGM80QD88 Notification type: INITIAL NOTIFICATIONReference number: 743700205JAMGM80QD88_20181105085245_3 ____________________________________________ Transaction date: 2018-11-02Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007306Nature of the transaction: ACQUISITION Transaction details(1): Volume: 638 Unit price: 4.

Nomination Committee appointed in Instalco Intressenter AB

In accordance with the principles adopted by the general meeting in Instalco Intressenter AB held on 8 May 2018, the Nomination Committee shall be comprised of the Chairman of the Board of Directors and three members appointed by the three shareholders with the largest number of votes in the company. If either of the shareholders with the largest number of votes waives their right to appoint a member, the shareholder with the next largest shareholding shall be offered the opportunity to appoint a member.The Nomination Committee ahead of the 2019 AGM comprises the following members: •

Eurocines Vaccines AB will be transferred to Spotlight Stock Market’s ordinary list

Since October 22, 2018 Eurocines Vaccines AB:s share (EUCI) and subscription option (EUCI TO 2) have been traded on Spotlight Stock Market’s observation list. With reference to today’s press release from the company, Spotlight Stock Market has decided to transfer the company’s share to Spotlight Stock Market’s ordinary list as of today November 5th, 2018. Spotlight Stock Market+ 46 8-511 68 000E-mail: pressmeddelanden@spotlightstockmarket.com About Spotlight Spotlight Stock Market is a market place that wants to make it easier, safer and more visible for growth companies to

Application for clinical trial submitted to the Medical Products Agency, ProTrans-2.

NextCell Pharma AB ("NXTCL") today announced that a new application to conduct a clinical trial with ProTrans has been submitted to the Swedish Medical Products Agency. The purpose of the study is to evaluate repeated treatment with ProTrans, including patients with type 1 diabetes who participated in the dose escalating part of the original NXTCL trial.The ongoing clinical trial called ProTrans-1, was initiated with a dose escalation phase for 9 patients all followed for 12 months. After their last visit in the study, patients will be asked if they want to participate in a new study where

CEO presents TargetEveryone´s new platform

Torkel Johannessen gives the first presentation of TargetEveryone´s new platform version and the market potential. Follow the link https://www.targeteveryone.com/investors/presentations.php?lang=en&type=present or visit the Investor page at TargetEveryone.com. The platform provides marketeers with unique customer insight and allows segmenting both their markets and existing customer databases in a simple, fast and visual way. TargetEveryone has developed a great solution, that can scale and has global potential. With the new platform version our clients can now: 1. Perform deep

Moberg Pharma signs exclusive agreement for Emtrix® in the Middle East and Africa

STOCKHOLM, November 5th, 2018, Moberg Pharma AB (OMX: MOB) has signed an exclusive agreement with Mundipharma to commercialize Emtrix® in the Middle East and Africa, starting in 2019.Moberg Pharma signs an exclusive agreement with Mundipharma to commercialize Emtrix®, Moberg’s lead fungal nail product. Moberg Pharma will exclusively supply the product, and Mundipharma will be responsible for local registration and commercialization in the Middle East and Africa, focusing initially on three markets in the region. “We look forward to developing our relationship with Mundipharma and making

EXTRAORDINARY GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Extraordinary General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, Wednesday 5 December 2018 at 3:00 p.m. Coffee will be served starting at 2:00 p.m., at which time the registration for attendees will commence.Right to participate and notice Shareholders who wish to participate at the Extraordinary General Meeting must be entered in the share register of the Company, kept by Euroclear Sweden AB (the Swedish

New Study Finds NEXT Biometrics’ Fingerprint Sensors Outperform Others in Key Biometric Measurements

Confirms Results of Study Published in 2015 Showing Larger Sensors Most AccurateOSLO, Nov. 5, 2018 -- NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, today announced the results of a new study by Carlos III University of Madrid (UC3M) showing that NEXT fingerprint sensors outperform sensors from three top competitors. NEXT sensors produced significantly lower biometric error rates during extensive testing. Biometric error rates ultimately determine the security and convenience of biometric authentication systems.                   The study confirms

Stillfront Group AB: Stillfront provides selected preliminary financial information for the third quarter 2018

NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL PRESS RELEASE November 5, 2018 Stillfront provides selected preliminary financial information for the third quarter 2018 As previously communicated, Stillfront Group AB (publ) ("Stillfront" or the "Company") is intending to meet with Nordic bond investors between November 7 and November 9, 2018 and is now

Biohit Oyj B-shares Subscribed with Stock Options I 2013

Biohit Oyj Stock Exchange Release November 5, 2018 at 09.30 a.m. (EEST) A total number of 52,709 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 5 June 2018 and 8 September 2018. These shares have been entered into the Trade Register on November 5, 2018, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on NASDAQ Helsinki as of November 6, 2018 together with the existing B-shares. The share subscription price was EUR 2.2766 per share respectively. The entire

Minesto News Update 5 November 2018

· Finance Secretary sets out marine energy ambition for Wales at OEE2018 · Wanted: Engineers who want to join the climate change fight · European Commission and Bill Gates’ Breakthrough Energy launch €100m clean energy investment fund · Minesto features on national television newsFinance Secretary sets out marine energy ambition for Wales at OEE2018 Europe's and the world's leading ocean energy developers gathered in Edinburgh for the annual Ocean Energy Europe (OEE) conference this week. OEE is one of the most important events on Europe’s ocean energy calendar, providing

SBB has repurchased bonds

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) today announces that SBB:s subsidiary in Norway B121 Holding AS (914 392 241) has repurchased bonds with a nominal value of NOK 130,000,000. The repurchase relates to junior bonds issued by the subsidiary B121 Holding AS with a nominal amount outstanding of NOK 390,000,000 including the volume now repurchased by SBB. The bonds have a fixed rate corresponding to 5.75 percent and are due in December 2020. The purchase price corresponds to 104.5 percent of the remaining outstanding nominal value of the bonds. Following the purchase, SBB’s

Etrion to Release Third Quarter 2018 Results on November 7, 2018

November 5, 2018, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its third quarter 2018 results before the market opens on Wednesday, November 7, 2018.   Operations and Finance Update call   A conference call webcast to present the Company’s third quarter 2018 Operations and Finance update will be held on Wednesday, November 7, 2018, at 10:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).    Dial-in details:  North America: +1-647-788-4991 / Toll Free: +1-877-

Invitation to Raketech’s Q3 2018 conference call

Raketech, a leading online affiliate and content marketing company, will publish its Q3 2018 interim report at 08.00 CET on 22 November. At 09.00 CET on the same day, the report will be presented in a conference call and audiocast by CEO Michael Holmberg and CFO Andreas Kovacs. The presentation will be followed by a Q&A session.To participate in the call, please dial: Sweden: +46 8 566 42 691UK: +44 203 008 9810US: +1 855 831 5946 The conference call can also be followed online at: https://tv.streamfabriken.com/raketech-q3-2018 For more information, please contact investor@

Distribution and listing of Nyfosa AB on Nasdaq Stockholm

The extraordinary general meeting of Hemfosa on September 13, 2018 resolved to distribute all of the shares in the subsidiary Nyfosa AB (“Nyfosa”) to the ordinary shareholders of Hemfosa. The Board of Directors was authorized to determine the record date for the distribution and the record date has now been set to November 21, 2018. The first day of trading in Nyfosa shares is expected to be November 23, 2018.Nasdaq Stockholm’s Listing Committee has approved that Nyfosa’s shares are admitted to trading on Nasdaq Stockholm. The approval is conditional on that customary conditions are met,

There are no items matching the current filter
There are no more items matching the current filter
Back to top